GB9508460D0 - Bittering formulation - Google Patents

Bittering formulation

Info

Publication number
GB9508460D0
GB9508460D0 GBGB9508460.4A GB9508460A GB9508460D0 GB 9508460 D0 GB9508460 D0 GB 9508460D0 GB 9508460 A GB9508460 A GB 9508460A GB 9508460 D0 GB9508460 D0 GB 9508460D0
Authority
GB
United Kingdom
Prior art keywords
bittering
formulation
bittering formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9508460.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOP DEV Ltd
Hop Developments Ltd
Original Assignee
HOP DEV Ltd
Hop Developments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOP DEV Ltd, Hop Developments Ltd filed Critical HOP DEV Ltd
Priority to GBGB9508460.4A priority Critical patent/GB9508460D0/en
Publication of GB9508460D0 publication Critical patent/GB9508460D0/en
Priority to EP96911051A priority patent/EP0822975A1/en
Priority to AU54052/96A priority patent/AU5405296A/en
Priority to PCT/GB1996/000993 priority patent/WO1996034086A1/en
Pending legal-status Critical Current

Links

GBGB9508460.4A 1995-04-26 1995-04-26 Bittering formulation Pending GB9508460D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9508460.4A GB9508460D0 (en) 1995-04-26 1995-04-26 Bittering formulation
EP96911051A EP0822975A1 (en) 1995-04-26 1996-04-24 Iso-alpha-acid formulation and its use
AU54052/96A AU5405296A (en) 1995-04-26 1996-04-24 Iso-alpha-acid formulation and its use
PCT/GB1996/000993 WO1996034086A1 (en) 1995-04-26 1996-04-24 Iso-alpha-acid formulation and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508460.4A GB9508460D0 (en) 1995-04-26 1995-04-26 Bittering formulation

Publications (1)

Publication Number Publication Date
GB9508460D0 true GB9508460D0 (en) 1995-06-14

Family

ID=10773542

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9508460.4A Pending GB9508460D0 (en) 1995-04-26 1995-04-26 Bittering formulation

Country Status (4)

Country Link
EP (1) EP0822975A1 (en)
AU (1) AU5405296A (en)
GB (1) GB9508460D0 (en)
WO (1) WO1996034086A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403480A1 (en) 2000-04-11 2001-10-18 Dupont Displays, Inc. Soluble poly(aryl-oxadiazole) conjugated polymers
WO2009049381A1 (en) * 2007-10-19 2009-04-23 Coopers Brewery Limited Home brew additives and method of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3607298A (en) * 1967-04-11 1971-09-21 Bush Boake Allen Ltd Hop concentrates
US3615660A (en) * 1969-06-11 1971-10-26 Pfizer Hop extract emulsion and preparation and use thereof
BE765456A (en) * 1971-04-08 1971-08-30 Prb Sa PROCESS FOR THE PREPARATION OF HOP EXTRACTS IN THE FORM OF A STABLE WATER-BASED EMULSION AND HOP EXTRACTS THUS PRODUCED.

Also Published As

Publication number Publication date
EP0822975A1 (en) 1998-02-11
WO1996034086A1 (en) 1996-10-31
AU5405296A (en) 1996-11-18

Similar Documents

Publication Publication Date Title
EP0846088A4 (en) Cement formulation
GB2313783B (en) Oral 2-Methyl-Thieno-Benzodiazepine formulation
GB9514842D0 (en) Novel formulation
GB9519363D0 (en) Pharmaceutical formulation
PL324453A1 (en) Sold greasea
EP0862431A4 (en) Pharmaceutical formulation
ZA9710601B (en) Novel formulation
AU7265796A (en) Probiotically acting formulation
GB9523566D0 (en) Pharmaceutical formulation
GB9508460D0 (en) Bittering formulation
ZA976592B (en) Formulation
GB9509291D0 (en) Formulations
HU9602732D0 (en) Lanperisone formulation
ZA965962B (en) Anti-piroplasmotic agent
GB9508684D0 (en) Novel formulation
GB9404989D0 (en) Lipomimetric formulation
CA76097S (en) Can
GB9510349D0 (en) Formulations
GB9509941D0 (en) Formulations
GB9508144D0 (en) Formulations
AU127376S (en) Can jack
GB9509559D0 (en) Gel formulation
HU9500171V0 (en) Wood- dave ment
GB9514644D0 (en) Sustained-release formulation
PL307196A1 (en) Pharmaceutcal agent